Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Olanow

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Archives of Neurology|February 20, 1999
Long-term evaluation of bilateral fetal nigral transplantation in Parkinson diseaseR A Hauser, T B Freeman, B J Snow, et al.
Trends in Neurosciences|October 29, 2000
Pathophysiology of the basal ganglia in Parkinson's diseaseJ A Obeso, M C Rodríguez-Oroz, M Rodríguez, et al.
AJR. American Journal of Roentgenology|August 1, 1983
Age-related changes in the thymus gland: CT-pathologic correlationA V Moore, M Korobkin, W Olanow, et al.
Annals of Neurology|November 1, 1995
The effect of deprenyl and levodopa on the progression of Parkinson's diseaseC W Olanow, R A Hauser, L Gauger, et al.
Acta Neuropathologica|January 1, 1996
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's diseaseV Buée Scherrer, P R Hof, L Buée, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletionC Mytilineou, E K Leonardi, P Radcliffe, et al.
The Journal of Clinical Investigation|March 1, 1984
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycleR L Sabina, J L Swain, C W Olanow, et al.
Clinical Neuropharmacology|June 1, 1991
An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patientsC W Olanow, K Nakano, P Nausieda, et al.
Cell Transplantation|January 1, 1995
The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral graftsT B Freeman, P R Sanberg, G M Nauert, et al.
Experimental Neurology|September 1, 1991
Development of dopaminergic neurons in the human substantia nigraT B Freeman, M S Spence, B D Boss, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Archives of Neurology|February 20, 1999
Long-term evaluation of bilateral fetal nigral transplantation in Parkinson diseaseR A Hauser, T B Freeman, B J Snow, et al.
Trends in Neurosciences|October 29, 2000
Pathophysiology of the basal ganglia in Parkinson's diseaseJ A Obeso, M C Rodríguez-Oroz, M Rodríguez, et al.
AJR. American Journal of Roentgenology|August 1, 1983
Age-related changes in the thymus gland: CT-pathologic correlationA V Moore, M Korobkin, W Olanow, et al.
Annals of Neurology|November 1, 1995
The effect of deprenyl and levodopa on the progression of Parkinson's diseaseC W Olanow, R A Hauser, L Gauger, et al.
Acta Neuropathologica|January 1, 1996
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's diseaseV Buée Scherrer, P R Hof, L Buée, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletionC Mytilineou, E K Leonardi, P Radcliffe, et al.
The Journal of Clinical Investigation|March 1, 1984
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycleR L Sabina, J L Swain, C W Olanow, et al.
Clinical Neuropharmacology|June 1, 1991
An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patientsC W Olanow, K Nakano, P Nausieda, et al.
Cell Transplantation|January 1, 1995
The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral graftsT B Freeman, P R Sanberg, G M Nauert, et al.
Experimental Neurology|September 1, 1991
Development of dopaminergic neurons in the human substantia nigraT B Freeman, M S Spence, B D Boss, et al.
Pageof 13